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Objective: The objective of this study was to analyse the dispensing patterns of vitamins (Anatomical Therapeutic Chemical (ATC) 
group A11) over a one-year period in a group of community pharmacies in South Africa.
Design and setting: A retrospective drug utilisation study was conducted on community pharmacy electronic dispensing records 
in South Africa recorded in 2013.
Outcome measures: All products for ATC subgroup A11 were extracted and analysed.
Results: A total of 164 233 vitamin products were dispensed to 84 805 patients (62.64% female patients). Males received on 
average 2.09 (SD = 2.63) vitamin products per year, compared to 1.84 (SD = 2.13) products for females. Ergocalciferol (A11CC01) 
was the most often dispensed (37.48% of all vitamin products), followed by plain Vitamin B-complex products (A11EA00) 
accounting for 32.77%. Ergocalciferol (vitamin D2) is only available on prescription (50 000 IU tablets or 50 000 IU/ml oily drops) 
in South Africa. Tablets were the preferred dosage form (62.84% of products). Most injections were for Vitamin B1 or Vitamin B 
combination products.
Conclusion: Ergocalciferol and injectable vitamins have recently been rescheduled to prescription-only; it is probable that this 
has impacted on the usage of these products. It is important to monitor future vitamin supplementation behaviour in community 
pharmacies since pharmacies are selling many of these products and pharmacists can, by counselling patients, determine the 
reasons for the use of these products. Furthermore, should dietitians and nutritionists choose to work with this captive audience, 
supplementation patterns can be monitored to develop and implement appropriate awareness campaigns. Further studies to 
explore these baseline results are recommended.
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Introduction
“Nutriceuticals/nutraceuticals” and “pharmaconutricals” are 
terms coined from “nutrition” and “pharmaceutical” to indicate a 
special therapeutic role for a food or food substance in the 
prevention and management of specific disease states.1, 2 
Nutraceuticals may include vitamins, minerals, amino acids and 
fatty acids, and differ from dietary supplements, as these not only 
supplement an individual’s diet, but also aid in the prevention 
and/or treatment of a disease.2 Vitamin D deficiency, for example, 
was reported in 2011 to be extremely common in black Africans 
living in Cape Town, and it was associated with susceptibility to 
tuberculosis (TB) infection.3 It was concluded that vitamin D 
supplementation may be a highly cost-effective, safe and simple 
means to reduce TB incidence.3 In a study recently reported by 
Busse et al.,4 the negative impact of vitamin D deficiency on bone 
health, specifically the higher risk for bone fractures was 
demonstrated; however, its impact on other health areas is less 
clear. Vitamin D deficiency has been suggested, for example, to 
play a role in depression5 and has also been associated with 
increased HIV-1 replication in HIV-infected individuals.6
It is well known that dietary supplement use in the United States 
of America (USA) is exceedingly high, with multivitamins and 
multiminerals the most frequently taken dietary supplement 
across all NHANES (National Health and Nutrition Examination 
Survey) years.7 About 39% of US residents have used at least one 
multivitamin and multimineral during the 2003 to 2006 survey 
period, and use was more prevalent in females.7 Further USA data 
suggest that adults and adolescents with suboptimal intakes of 
vitamins from food sources are less likely to be dietary supplement 
users.8 It was also observed that some subgroups of the population 
may be at risk for excessive intakes.8 Despite the high intake of 
multivitamins and multiminerals, tools to quantify intake and the 
potential public health impact of the use of dietary supplements 
were lacking. However, an integrated dietary supplement 
ingredient database was recently implemented in the USA.9 The 
collection and analysis of data on dietary supplement provides 
important quantitative indicators regarding the exposure and 
potential public health impact of dietary supplements.
Vitamin A and iron deficiencies in South Africa are widespread, and 
inadequate dietary intakes have been attributed to be the most 
important cause of these deficiencies.10 Micronutrient 
supplementation is routinely available to patients in the public health 
sector in South Africa, especially for pregnant and lactating women 
and vulnerable children at risk of developing malnutrition, as well as 
patients with infectious diseases.11 However, there is little published 
data available regarding the use of vitamins and minerals acquired 
from community pharmacies, despite the prevalent dispensing 
thereof. Survey results are available regarding dietary supplement 
use in certain cohorts,12 as well as the impact of marketing of 
nutritional or dietary supplements and resulting supplement choices 
by study participants in South Africa.13 In addition, the schedules of 
some vitamin formulations have recently been changed, and it will be 
important to monitor the impact of these changes in follow-up 
studies. This study was therefore conducted to inform on current 
dispensing patterns of vitamins in community pharmacies and to 
establish a baseline for further research.
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The primary aim of the study was to analyse the dispensing 
patterns of vitamins (specifically the Anatomical Therapeutic 
Chemical (ATC) group A11)15 over a one-year period in a group of 
community pharmacies in South Africa. Secondary objectives 
included analysis of these patterns by age and gender.
Methodology
Study design and setting
A retrospective, cross-sectional drug utilisation study was 
conducted on a community pharmacy dispensing database of 
approximately 54 million records dispensed by 327 community 
pharmacies in 2013 in South Africa. The term “community 
pharmacy” (also known as “retail pharmacy”) refers to a pharmacy 
wherein, or from which, some or all of the services as prescribed 
in terms of regulation 18 of the Regulations Relating to the 
Practice of Pharmacy in the Pharmacy Act are provided to the 
general public or any defined group of the general public, but 
excludes an institutional pharmacy (for example, a hospital 
pharmacy). According to the South African Pharmacy Council, 
there are 3  082 registered community pharmacies in South 
Africa.14 The data therefore represented approximately 10% of all 
community pharmacy dispensing records in 2013. The database 
consisted of dispensing information from pharmacies in all nine 
provinces of South Africa. It included dispensing records from all 
the pharmacies participating in the database. Products included 
both medical aid claims and products that were purchased from 
the pharmacies’ dispensaries. Thus, it included all vitamins 
prescribed by the clinicians, as well as those dispensed by 
pharmacists without a prescription, and that were recorded by 
the dispensing program of the pharmacy.
Approximately half of the supplements were claimed from 295 
different medical aid scheme options (plans), 35.66% of the 
products were claimed as over-the-counter (OTC) products, and 
13.47% were private purchases.
Data analysis
The Anatomical Therapeutic Chemical (ATC) Classification 
System,15 Monthly Index of Medical Specialities (MIMS)16 and the 
South African Medicines Formulary1 were used to classify 
medicines. The ATC Classification system is recommended by the 
World Health Organisation as the standard medicine classification 
system for drug utilisation studies in the world in order to enable 
comparative studies to be conducted. All products in ATC 
subgroup A11 were extracted and analysed. This ATC classification 
system is acknowledged worldwide; products are screened by 
an expert panel before receiving an ATC code. It is recognised 
that some vitamins are also included in other ATC groups, such as 
Vitamin K under anti-haemorrhagics (ATC code B02B) and 
Vitamin B12 under anti-anaemic preparations (ATC code B03B). 
These products were not included in this study. This study 
focused exclusively on products classified under ATC group A11.
Each medication record contained information on the age and 
gender of the patient, with a unique number to identify each 
patient, the date of the prescription, detailed information on the 
dispensed drug (name, package size, formulation, strength and 
quantity) and gross sales value. Dosage instructions were given, 
but were not consistently recorded.
Microsoft Access® and Excel® (part of the Microsoft Office 
Professional Plus 2013® package) were used to analyse the data. 
Descriptive statistics were calculated. The results were described 
according to means and standard deviations for numerical data, 
and frequencies and percentages for categorical data. The 
Pearson’s chi-squared test was used to determine statistical 
significant differences between sub-groups. A p-value < 0.05 was 
considered statistically significant.
Ethical approval
Ethical approval to conduct studies on prescription databases 
was obtained from the Research Ethics Committee (Human) of 
the Nelson Mandela Metropolitan University (ethics clearance 
number: H08-HEA-PHA-005). The dispensing records were de-
identified, meaning that no patient nor prescriber could be 
identified. A patient identifier was added to enable the 
researchers to uniquely identify each patient in terms of age and 
gender, and to calculate the number and spectrum of products 
that a specific patient received, but it was a neutral code and not 
an identity or medical aid number.
Limitations of the study
A major limitation of the study was that only vitamins that were 
recorded by the dispensary were included in the study. 
Unscheduled vitamins that were purchased in the front-shop of 
the pharmacy and paid for at the cashier, were not included in 
the study. Further limitations of the study included: no clinical 
information was available in the database; and that the study 
only covered a one-year period (1 January 2013 to 31 December 
2013). Other limitations included the exclusion of the analysis of 
vitamin K (ATC code B02B) and Vitamin B12 preparations (ATC 
code B03B) from this study. The analysis of the records for these 
vitamins would have provided important indicators of 
compliance in terms of only dispensing with a prescription, as 
well as the prevalence of the dispensing of these vitamins. 
Although dosage instructions were captured on the system, 
these were not consistently recorded, which potentially 
influenced or skewed the results.
Results
Demographic information
A total of 164  233 vitamin products were dispensed to 84  807 
patients at a cost of ZAR7  689  306.34 in 2013. The majority of 
patients were females (n = 53 123; 62.64%). The average age of 
patients was 47.53 (SD = 16.17) years (females: 46.33 (SD = 16.12) 
years; males: 49.54 (SD = 16.06) years).
Number of products dispensed
The products were predominantly dispensed to patients 
between the ages of 30 and 59  years, as shown in Figure 1. 
Females in the 30 to 39-year age group were dispensed 21.95% 
of products compared with males (16.15%). The chi-square test 
was used to detect differences between female and male 
patients in the different age groups. Differences (χ2  = 2513.0; 
d.f.  = 5; p  < 0.0001) were observed, after collapsing the small 
clusters below 30  years of age and above 70  years of age 
together.
Males received on average 2.09 (SD = 2.63) vitamin products over 
the year, compared to 1.84 (SD  = 2.13) products for females. 
However, patients that were dispensed with ergocalciferol 
(vitamin D2) tablets received on average 3.38 (SD  = 3.41) 
products per year, and those that were dispensed calcitriol 
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(1,25-dihydroxyvitamin D3) received 4.84 (SD  = 4.47) products 
per year. The number of vitamin products dispensed increased 
steadily over the year, as can be seen in Figure 2, with no seasonal 
peak during May to August, the winter season.
Prescribing of the different vitamin active ingredients
The percentage frequency distribution of the different 
vitamin active ingredients according to gender is given in 
Table 1. Ergocalciferol (vitamin D2) was the most frequently 
dispensed (37.48% of all vitamin products), followed by plain 
Vitamin B-complex products (A11EA00) accounting for 
32.77% of products. Alphacalcidol (1-apha-hydroxyvitamin 
D3) reflected only 2.52% of the products and calcitriol 
(1,25-dihydroxyvitamin D3) only 0.49% of the dispensed 
products. In the Vitamin B-complex products category, 
vitamin B-complex tablets (56.88%) were more frequently 
dispensed, and 43.12% as Vitamin B-complex 10 mg/ml vials. 
Neurobion® injections, containing a combination of 100 mg 
of Vitamin B1, 100 mg of Vitamin B6 and 1 mg of Vitamin B12, 
reflected 9.69% of the products.
The frequency distributions of products according to age and 
gender for the two most often dispensed groups are compared 
in Figures 3(a) and 3(b). Interestingly, most products for 
ergocalciferol (vitamin D2) were dispensed for patients older 
Figure 1: Percentage of products dispensed by gender in the different 
age groups (N = 164 233).
Figure 2: Frequency of vitamin products dispensed by gender over the 
12 months (N=164 233).
Table 1: Frequency distribution of the different vitamin active 
ingredients according to gender (N = 164 233)
ATC Groups Percentage (%) Both genders








6.88 4.58 9773 5.95
A11B Multivitamins, plain
A11BA01 Multivita-mins, plain 1.04 1.06 1720 1.05
A11C Vitamin A and D, including combinations of the two
A11CC01 Ergocalciferol 36.15 39.44 61552 37.48
A11CC03 Alfacalcidol 1.58 3.92 4144 2.52
A11CC04 Calcitriol 0.37 0.67 808 0.49
A11D Vitamin B1, plain and in combination with vitamin B6 and B12
A11DA01 Thiamine (Vit B1) 14.63 16.53 25291 15.40

















0.20 0.29 387 0.24
A11G Ascorbic acid (vitamin C), including combinations






0.001 0.00 1 0.00
A11H Oher plain vitamin preparations
A11HA02 Pyridoxine (Vitamin B6) 0.001 0.00 1 0.00
A11HA03 Tocopherol (Vitamin E) 0.004 0.003 6 0.00
A11HA07 Inositol 0.002 0.00 2 0.00
A11 J Other vitamin products, combinations





3.54 3.18 5574 3.39
TOTAL 100.00 100.00 164 233 100.00
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tablets and 609 calciferol oil 5 000 IU/ml drops). A total of 23 208 
vitamin B-complex (Vitamin B6) 10 mg/ml vials were dispensed 
(also Schedule 3).
Cost of vitamin products dispensed
The average cost per vitamin product was ZAR46.82 
(SD = ZAR367.45). The average cost per product for females was 
ZAR43.74 and for males ZAR51.37. The percentage frequency 
versus the percentage cost of vitamin products in 10-year age 
groups are compared in Figure 5. The 30 to 39-year age group 
accounted for the largest percentage of cost (45.29%). Within 
that age group, 28.93% of the cost was due to the dispensing of 
a combination vitamin and mineral product marketed for 
pregnant female patients, or a vitamin and mineral syrup.
Discussion
Vitamin D has been described as “a nutraceutical that has 
exploded onto the prescription pad” in recent years17, and is 
known to be widely deficient in Western populations.18 Despite 
numerous observational studies on plasma vitamin D 
concentrations, as well as randomised controlled trials, no 
consensus exist on optimal vitamin D intake and 
supplementation.19 In the umbrella review by Theodoratou 
et al.,19 it was suggested that low plasma vitamin D is a marker of 
compromised health, but not necessarily a cause of disease.
In this study, it was evident that vitamin D supplements and 
specifically ergocalciferol (vitamin D2) are still widely used, since 
it was the product most often dispensed by participating 
pharmacies in the sample. It was probably due to the perceived 
benefits in relation to specifically bone health; however, the 
usage may be influenced by exposure to reports in the media 
which highlight the wide prevalence of vitamin D deficiency and 
associations with other health problems (for example, depression 
and rheumatoid arthritis).20 Despite the documented benefits, 
the 2011 Daily Recommended Intakes for vitamin D only 
recommend levels of 400 IU/d for infants, 600 IU/d for children 
and adults through age 70 years, and 800 IU/d for ages 71 years 
and older.21
Owing to the prevalent dispensing of ergocalciferol to both 
genders, it may be of interest to investigate whether the use of 
vitamin D supplements is due to the perceived benefits of the 
vitamin by patients, clinicians or dietitians, hence further 
research is thus recommended. It would also be important to 
establish whether ergocalciferol is prescribed to treat low 
than 50 years, while vitamin B-complex products peaked at an 
earlier age (around 30 years).
Dosage forms and schedules dispensed
Vitamin tablets were the dosage form mostly dispensed (62.84%) 
compared with capsules (10.37%), vials (14.13%), injections 
(9.70%), followed by small amounts of chewable tables, drops 
and vitamin syrup. Most injections and vials were for vitamin B1 
or vitamin B-complex products.
Vitamins are either unscheduled, Schedule 0, 1, 2, 3 or 4.1 
Approximately half (54.62%) of the products were prescription-
only medicine (Figure 4). A total of 4 952 products were Schedule 
4 prescriptions (alfacalcidol or calcitriol). A total of 84  760 
products were classified as Schedule 3 (60 943 calciferol 50 000 IU 
Figure 3: (a) & (b) Frequency distributions of products according to age 
and gender for the two most often dispensed vitamin subgroups
Figure 4: Vitamins dispensed by schedule
Figure 5: Percentage frequency versus cost of products in 10 year-age 
groups
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work with this captive audience, supplementation patterns can be 
monitored to develop and implement appropriate awareness 
campaigns. This may prevent an excessive micronutrient intake in 
individuals at risk of exceeding the upper tolerable limits. Further 
research to determine reasons behind these dispensing patters is 
recommended.
Acknowledgements – This work is based upon research supported 
by the National Research Foundation (NRF). Any opinion, findings 
and conclusions or recommendations expressed in this paper 
are those of the author and therefore the NRF do not accept any 
liability in regard thereto.The organisation providing the data for 
the study.
References
1.  Rossiter D (editor). South African Medicines Formulary (SAMF) (11th 
ed.). Cape Town: Health and Medical Publishing Group of the South 
African Medical Association; 2014.
2.  Kalra, E. K. Nutraceutical-definition and introduction. AAPS PharmSci. 
2003;5(3):27–8. c2016. doi: 10.1208/ps050325.
3.  Martineau AR, Nhamoyebonde S, Oni T, et al. Reciprocal seasonal 
variation in vitamin D status and tuberculosis notifications in Cape 
Town, South Africa. Proc Natl Acad Sci. 2011;108(47):19013–7. 
http://dx.doi.org/10.1073/pnas.1111825108
4.  Busse B, Bale H, Zimmermann E, et al. Vitamin D deficiency induces 
early signs of aging in human bone, increasing the risk of fracture. Sci 
Transl Med. 2013;5(193):193ra88.
5.  Berk M, Sanders KM, Pasco JA, et al. Vitamin D deficiency may 
play a role in depression. Med Hypotheses. 2007;69:1316–9. 
http://dx.doi.org/10.1016/j.mehy.2007.04.001
6.  Coussens AK, Naude CE, Goliath R, et al. High-dose vitamin D 3 reduces 
deficiency caused by low UVB exposure and limits HIV-1 replication 
in urban Southern Africans. Proc Natl Acad Sci. 2015;112(26):8052–7. 
http://dx.doi.org/10.1073/pnas.1500909112
7.  Gahche J, Bailey R, Burt V, et al. 2011. Dietary supplement use among 
U.S. adults has increased since NHANES III (1888-1994). NCHS data 
brief, no 61. Hyattsville (MD): National Center for Health Statistics.
8.  Rock CL. Multivitamin-multimineral supplements: who uses them? 
Am J Clin Nutr. 2007;85(Supplement):277S–9S.
9.  Dwyer JT, Frances Picciano M, Betz JM, et al. Progress in development 
of an integrated dietary supplement ingredient database at the NIH 
Office of Dietary Supplements. J Food Compos Anal. 2006;19:S108–14. 
http://dx.doi.org/10.1016/j.jfca.2005.09.001
10.  Faber M, Wenhold F. Nutrition in contemporary South Africa. Water 
SA. 2007;33(3):393–400.
11.  Department of Health. 2013. Roadmap for Nutrition in South Africa 
2013-2017. C2016. Available from: https://extranet.who.int/nutrition/
gina/sites/default/files/ZAF%202013%20Roadmap%20for%20
Nutrition%20in%20South%20Africa%20.pdf.
12.  Steele M, Senekal M. Dietary supplement use and associated factors 
among university students. S Afr J Clin Nutr. 2005;18(1):17–30.
13.  Schoonees A, Young T, Volmink J. The advertising of nutrition 
supplements in South African women’s magazines: a descriptive 
survey. S Afr J Clin Nutr. 2013;26(2):62–8.
14.  Statistics for registered persons and organisations. South African 
Pharmacy Council. 2015. c2016. Available from: http://www.
pharmcouncil.co.za/B_Statistics.asp.
15.  ATC/DDD Index 2015. Oslo: WHO collaborating centre for drug 
statistics methodology. 2015. Available from: http://www.whocc.no/
atc_ddd_index/.
16.  Snyman JR, editor. MIMS Monthly Index of Medical Specialities (MIMS). 
Saxonwold: MIMS. 2011;51(6):1–2.
17.  Braithwaite MC, Kumar P, Tyagi C, et al. Vitamin D therapy and related 
metabolomics: Is the calciferol dose and form the only requirements 
for successful clinical therapeutics? Med Hypotheses. 2013;81:656–63. 
http://dx.doi.org/10.1016/j.mehy.2013.07.022
18.  Hoffmann MR, Senior PA, Mager DR. Vitamin D Supplementation 
and Health-Related Quality of Life: A Systematic Review 
of the Literature. J Acad Nutr Dietetics. 2015;115:406–18. 
http://dx.doi.org/10.1016/j.jand.2014.10.023
25-hydroxyvitamin D levels, to prevent bone disease, or due to 
the perceived value as a nutraceutical. In the absence of vitamin 
D deficiency, ergocalciferol supplementation may result in 
intakes approaching upper limits of 4000 IU/d that may result in 
declining benefits. There is emerging evidence of a U-shaped 
curve associated with vitamin D supplementation for all-cause 
mortality, as well as morbidity.21
Although vitamin B-complex in tablet form was the product 
most often dispensed, vitamin B vials and injections accounted 
for more than 20% of products. It should be noted that vitamin B 
injections have recently been rescheduled in South Africa to 
prescription-only products, and consumers therefore can no 
longer buy these products directly from a pharmacy or ask the 
pharmacist to administer a vitamin B injection without a 
prescription.22
The vitamin and mineral supplementation market in South Africa 
in 2015 was worth approximately ZAR2.9 billion and growing 
annually at a rate of 7%.23 It can be assumed that most consumers 
prefer to buy unscheduled vitamin and mineral supplements in 
retail stores or health shops rather than community pharmacies. 
We speculate consumers in South Africa are probably 
predominantly dependent on marketing from manufacturers 
and retailers to obtain accurate information about vitamin 
products they purchase. Since consumers normally do not seek 
professional advice prior to purchasing vitamin products,24 it is 
important for dietitians to utilise all potential opportunities to 
educate vitamin product users about responsible 
supplementation. The results from this retrospective analysis 
predominantly reflect trends in relation to scheduled products. 
However, it was interesting to observe that a large number of 
patients still receive dispensed vitamin products which were 
either prescribed by a physician or dispensed by a pharmacist 
after consultation with a patient. This is especially true in relation 
to vitamin D supplementation and currently there is limited 
information about the reasons for vitamin D use in South Africa. 
Dietitians and nutritionists need to be aware of this captive 
audience and should work with pharmacists to interpret 
prescription and dispensing patterns and create referral systems 
for patients that may need additional nutrition counselling.
Conclusion and recommendations
Vitamins are important in treating nutritional deficiencies, yet 
few studies on vitamins have been conducted in pharmacies. 
Vitamin D2, vitamin B-complex (plain preparations) and vitamin 
B1 together, accounted for more than 85% of all vitamin products 
dispensed in ATC group A11.
It is expected that the restriction on the over-the-counter 
availability of vitamin B injections in South Africa will impact on 
the dispensing and usage patterns. It will be important to 
monitor the effect that this change in prescribing status will have 
on vitamin sales in pharmacies.
The study had various limitations, yet a baseline was established 
for further studies. It is important to monitor future vitamin 
supplementation behaviour in community pharmacies since 
pharmacies are selling many of these products and pharmacists 
can, by counselling patients, determine the reasons for the use of 
these products. There is also a need to develop a comprehensive 
vitamin database that includes clinical data (such as comprehensive 
diagnoses (the ICD10 code) and laboratory markers, where 
available). There is also a need for prospective studies to be 
conducted in this field. Furthermore, should dietitians choose to 
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